🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

5 big analyst picks: Morgan Stanley raised to Buy, Holley jumps on two upgrades

Published 13/07/2023, 10:10
© Reuters.
MS
-
SEE
-
SPWRQ
-
IART
-
HLLY
-

Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: upgrades at Morgan Stanley, Holley, Sealed Air, SunPower, and Integra LifeSciences.

InvestingPro subscribers got this news first. Never miss another market-moving headline.

Morgan Stanley raised to Buy

Odeon Capital upgraded Morgan Stanley (NYSE:MS) to Buy from Hold with a price target of $94.00.

The firm noted that despite Fed pledging to raise interest rates, its balance sheet has seen a minimal decline of less than 1% since February. Furthermore, it has given no indication of intending to increase quantitative tightening. Thus, Odeon expects a favorable flow of money, benefiting Morgan Stanley’s business model.

The firm also predicts a strong M&A market and increased earnings potential, making Morgan Stanley an attractive investment.

Holley stock jumps on two upgrades

Holley (NYSE:HLLY) shares surged more than 21% yesterday after two Wall Street firms upgraded the company, as reported in real time on InvestingPro. JPMorgan upgraded the company to Overweight from Neutral with a price target of $7.00, while BofA Securities upgraded to Buy from Neutral with a price target of $6.00 (from $3.25).

JPMorgan said the rating change was based on valuation and anticipated revenue growth in 2023 and 2024. The bank also expects improved profit margins and reduced leverage ratios resulting from growth and debt reduction.

According to BofA, web traffic data indicates potential revenue growth in Q2. The bank anticipates that recent cost cuts will lead to enhanced operating leverage and identify an opportunity for margin improvement.

Sealed Air earns another upgrade

Sealed Air (NYSE:SEE) received its second upgrade this week after a significant decline in share performance recently.

Baird upgraded the company to Outperform from Neutral with a price target of $49.00, noting it believes that the market already assumes a reduction in 2023 earnings expectations as the baseline assumption.

Earlier this week, BofA Securities upgraded the company to Buy from Neutral with a price target of $52.00 (from $61.00).

2 more upgrades

Raymond James upgraded SunPower (NASDAQ:SPWR) to Strong Buy from Outperform with a price target of $21.00. Shares jumped more than 8% yesterday.

Jefferies upgraded Integra LifeSciences (NASDAQ:IART) to Buy from Hold with a price target of $53.00 (from $58.00). Shares gained more than 3% yesterday.

Get ready to supercharge your investment strategy with our exclusive discounts.

Don't miss out on this limited-time opportunity to access cutting-edge tools, real-time market analysis, and expert insights. Join InvestingPro today and unlock your investing potential. Hurry, the Summer Sale won't last forever!

summer sale

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.